FDA Licensed Pfizer Vaccine Without Following Normal Approval Process, Documents Reveal

Zachary Stieber

U.S. drug regulators acknowledged deviating from the normal vaccine approval process when dealing with Pfizer’s COVID-19 shot, according to newly disclosed documents.

Weeks after Pfizer and its partner BioNTech announced they started a rolling submission of documents for approval of their COVID-19 vaccine, a U.S. Food and Drug Administration (FDA) official penned a memorandum authorizing the release of a Biologics License Application (BLA) number for the shot even as regulators weighed whether to approve the BLA, one of the documents shows.

… A separate document made public this week showed that the license number was given to Pfizer even though no approval decision had been made after Pfizer requested it.

… The FDA, which has never rejected an EUA or BLA request from Moderna or Pfizer related to their COVID-19 vaccines, and the Centers for Disease Control and Prevention, made a trend of bypassing the advisory panels during the pandemic, including when they authorized and recommended boosters in the fall of 2022 without any clinical data.

Latest articles

Rebecca Park Totilo Essential Oils for radiation sickness, biological warfare, chemical warfare...
Rebecca Park Totilo Living Grand Convention that inflammation is a signal that...
Maharishi Ayurveda Products International, Inc. Radiation—energy that travels through the atmosphere as...
Alan V. Schmukler There are numerous substances which are rumored to offer...
World Health Organization This document describes protocols and practices for ensuring the...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!